Profiling in Oncology using Solid Tumor Testing and Liquid Biopsy
Urvashi Bahadur,
Urvashi Bahadur 2nd degree connection2nd Vice President-Clinical Diagnostics ,
Strand Life Sciences
Genomic profiling of a tumor can provide valuable insight into its biology. Next Generation Sequencing (NGS) can simultaneously profile tumors for multiple, therapeutically relevant mutations with far greater sensitivity than other conventional sequencing methods. Results of such testing can also suggest novel therapeutic approaches indicating response to a drug approved for other tumor types or drugs in trials. Liquid biopsy allows for profiling via detection of traces of tumor DNA in the blood of an individual. Such testing is useful in investigating new changes in a tumor, such as the development of acquired resistance or recurrence. These topics will be discussed in detail in the presentation.
|
|
.jpg)